latest news on glp 1 drugs Weight loss and addiction: Study shows GLP-1 may help reduce overdose risks Risks of Ozempic, other GLP-1

Description

John Horneff, an associate professor of orthopedic surgery at the University of Pennsylvania and the lead author of the study, told NBC News

Concerns like thyroid cancer, pancreatitis, gallstones, gastroparesis, eye disease, and issues with bone health have all been linked to the use of GLP1 medications

524,525 Pancreatic cancer Researchers first compared the expression of GLP-1R in human pancreatic cancer tissues with adjacent non-tumorous pancreatic tissues, finding generally lower or absent expression of GLP-1R in pancreatic cancer tissues

You may start to see weight loss around 2 weeks, but for some, it may take longer

Why Biological Intervention Matters : According to obesity medicine research published in peer-reviewed journals, traditional behavioral weight loss interventions (diet and exercise alone) typically achieve only 2-4% body weight reduction, with 80-95% of individuals regaining lost weight within 1-5 years due to powerful biological adaptations including: Metabolic rate reduction (adaptive thermogenesis) Hunger hormone dysregulation (increased ghrelin, decreased leptin) Increased appetite and food preoccupation Reduced satiety signaling Enhanced calorie absorption efficiency Decreased energy expenditure during physical activity These biological adaptations explain why "eat less, move more" advice, while physiologically accurate, proves insufficient for most individuals struggling with obesity-their bodies actively resist sustained weight loss through multiple redundant biological mechanisms